Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY : OTC)

• Company Description    - Number of Employees: 2,100

• Price / Volume Information    Yesterday's Closing Price: $2.59 Daily Weekly Monthly 20 Day Moving Average: 31 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $5.00 52 Week Low: $2.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -0.74% 12 Week -10.69% -13.14% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6F. NO. 2 ALY. 36 LN. 26 RUIGUANG RD. - Taipei City,F5 114 TWN ph: 886-2-2790-1555 fax: - public01@bora-corp.com http://www.bora-corp.com

• General Corporate Information    Officers Sheng Pao-Shi - Chief Executive and Chairman Wang Chin-Chu - Director Chen Kuan-Pai - Director Yao Leroy - Director Lai Ming-Jung - Director Peer Information Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (CHCR) Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (ESRX) Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (MYDP) Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (COR) Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (GBCS) Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 09952D100 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/14/26 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/26

• Fundamental Ratios P/E Current FY Estimate: 8.35 Trailing 12 Months: 9.96 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -7.11% vs. Previous Quarter: -18.62% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - 28.34 ROA 06/30/26 - - 03/31/26 - - 12/31/25 - 9.99 Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1.45 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1.20 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - 23.25 Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - 15.70 Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - 27.76 Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - - Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - 3.21 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - 0.68 Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - 40.30

Powered by Zacks Investment Research ©